Organon & Co Ordinary Shares (OGN)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$6.75

Buy

$6.83

arrow-down$-0.15 (-2.15%)

Prices updated at 19 Dec 2025, 00:39 EST

Prices minimum 15 mins delay

Prices in USD

S&P 500

0.79%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - General

Chairman

Ms. Carrie S. Cox

CEO

Mr. Joseph T. Morrissey, Jr

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

10,000

Head office

30 Hudson Street

Jersey City

United States

07302

+1 551 430-6900

-

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Ms. Carrie S. Cox Executive Chairman of the Board	0.25m
Ms. Grace Puma Whiteford Independent Director	0.12m
Ms. Ramona A. Sequeira Director	-
Mr. Joseph T. Morrissey, Jr Interim Chief Executive Officer, Executive Vice President and Head of Manufacturing and Supply	0.75m
Mr. Matthew M. Walsh Executive Vice President, Chief Financial Officer and Principal Accounting Officer	0.90m
Ms. Rochelle B. Lazarus Independent Director	0.12m
Ms. Shalini Sharp Independent Director	0.15m
Mr. Robert A. Essner Independent Director	0.14m
Dr. Helene D. Gayle, M.D. Independent Director	0.12m
Ms. Cynthia M. Patton Independent Director	0.13m
Dr. Juan Camilo Arjona Ferreira, M.D. Executive Vice President, Head of Research and Development and Chief Medical Officer	0.65m
Mr. Daniel Karp Executive Vice President, Corporate Development	-
Dr. Alan Ezekowitz, M.D.,PhD Independent Director	0.13m
Ms. Rachel A. Stahler Executive Vice President and Chief Digital and Growth Officer	-
Ms. Kathryn DiMarco Senior Vice President and Corporate Controller	-
Mr. Aaron Falcione Executive Vice President and Chief Human Resources Officer	-
Mr. Vittorio Nisita Executive Vice President and Head of Enterprise Services and Solutions	-
Ms. Deborah R. Leone Independent Director	0.13m
Dr. Philip Ozuah, M.D.,PhD Independent Director	0.13m
Mr. Kirke Weaver Executive Vice President, General Counsel and Corporate Secretary	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	32,277,543
BlackRock Inc	30,858,689
BlackRock Fund Advisors	21,692,787
iShares Core S&P Small-Cap ETF	15,505,426
MFS Investment Management KK	9,502,102

Director dealings

Date chevron-l-regular chevron-r-regular	Action
07 Nov 2024	-
07 Nov 2024	-
07 Nov 2024	-
03 Sep 2024	-
03 Sep 2024	-
03 Sep 2024	-
03 Sep 2024	-
03 Sep 2024	-
03 Sep 2024	-
03 Sep 2024	-
03 Sep 2024	-
03 Sep 2024	-
03 Sep 2024	-
03 Sep 2024	-
03 Sep 2024	-
03 Sep 2024	-
03 Sep 2024	-
03 Sep 2024	-
03 Sep 2024	-
11 Aug 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.